Literature DB >> 7050865

Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.

P T McEnery, C F Strife.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7050865

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


× No keyword cloud information.
  20 in total

1.  Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.

Authors:  Pietro Ravani; Alberto Magnasco; Alberto Edefonti; Luisa Murer; Rossella Rossi; Luciana Ghio; Elisa Benetti; Floriana Scozzola; Andrea Pasini; Nadia Dallera; Felice Sica; Mirco Belingheri; Francesco Scolari; Gian Marco Ghiggeri
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 8.237

Review 2.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

Review 3.  Genetics of idiopathic nephrotic syndrome.

Authors:  Abhay N Vats
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

4.  Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

Authors:  P Tarshish; J N Tobin; J Bernstein; C M Edelmann
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

5.  Serum and urine soluble interleukin-2 receptor in idiopathic nephrotic syndrome.

Authors:  G H Bock; J R Ongkingco; L T Patterson; J Ruley; L R Schroepfer; D L Nelson
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

6.  Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome.

Authors:  R N Srivastava; A S Vasudev; A Bagga; K R Sunderam
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

7.  Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.

Authors:  Pietro Ravani; Roberta Rossi; Alice Bonanni; Robert R Quinn; Felice Sica; Monica Bodria; Andrea Pasini; Giovanni Montini; Alberto Edefonti; Mirco Belingheri; Donatella De Giovanni; Giancarlo Barbano; Ludovica Degl'Innocenti; Francesco Scolari; Luisa Murer; Jochen Reiser; Alessia Fornoni; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2015-01-15       Impact factor: 10.121

8.  Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.

Authors:  K Al-Saran; K Mirza; G Al-Ghanam; M Abdelkarim
Journal:  Pediatr Nephrol       Date:  2005-10-13       Impact factor: 3.714

9.  Major histocompatibility complex antigens in steroid-responsive nephrotic syndrome.

Authors:  P T McEnery; T R Welch
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

10.  Heparin inhibits mesangial cell proliferation in habu-venom-induced glomerular injury.

Authors:  A K Coffey; M J Karnovsky
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.